Abiopharma

Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets

GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025

Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025

QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing

Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors

Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors